Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Repotrectinib shows high response rates, durable activity in ROS1 fusion–positive NSCLC

Repotrectinib shows high response rates, durable activity in ROS1 fusion–positive NSCLC

15 Jan 2024